Risk-adjusted capitation payment systems for health insurance plans in a competitive market

References

• Rice N, Smith PC. Capitation and risk adjustment in health care financing: an international progress report. Milbank 79,81–113 (2001).
   PubMed Web of Science ®Google Scholar
• Light DW. The practice and ethics of risk-rated health insurance. JAIVIA 267(18), 2503–2508 (1992).
   PubMed Web of Science ®Google Scholar
• GAO (US General Accounting Office). Health can reform: considerations for risk adjustment under community rating. GAO/ HEHS-94-173, Washington DC, USA (1994).
   Google Scholar
• Van de Ven WPMM, Ellis RP. Risk adjustment in competitive health plan markets. In: Handbook of Health Economics. Newhouse JP, Cuyler AJ (Eds). Elsevier, Amsterdam, Holland, 755–845 (2000).
   Google Scholar
• ••Provides a conceptual framework forthinking about risk-adjustment.
   Google Scholar
• Van de Ven WPMM, Van Vliet RCJA, Schut FT, Van Bameveld EM. Access to coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?' Health Econ. 19, 311–339 (2000).
   Google Scholar
• Bowen B. The practice of risk adjustment. Inquiry 32,33–40 (1995).
   PubMed Web of Science ®Google Scholar
• Gauthier AK, Lamphere JA, Barrand NL. Risk selection in the health care market: a workshop overview. Inquiry 32 (1), 14–22 (1995).
   PubMed Web of Science ®Google Scholar
• Luft HS, Miller RII. Patient selection in a competitive health care system. Health Affairs7, 97–119 (1988).
   Web of Science ®Google Scholar
• Van de Ven WPMM, Van Vliet RCJA. How can we prevent cream skimming in a competitive health insurance market? The great challenge of the 90's. In: Health Economics Worldwide. French T, Zweifel P (Eds). Kluwer Academic Publishers, Amsterdam, Holland (1992).
   Google Scholar
• Van de Ven WPMM, Beck K, Buchner F et al Risk adjustment and risk selection on the sickness fund market in five European countries. Health Policy65(1), 75–98 (2003).
   PubMed Web of Science ®Google Scholar
• •Gives an impression of risk-adjusted capitation payment systems currently used in Europe.
   Google Scholar
• Swartz K. Reducing risk selection requires more than risk adjustments. Inquiry32 (1), 6–10 (1995).
   PubMed Web of Science ®Google Scholar
• Van Bameveld EM, Lamers LM, Van Vliet RCJA, Van de Ven WPMM. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency. J. Health Econ. 20(2), 147–168 (2001).
   Google Scholar
• •Provides a review of forms of risk-sharing.
   Google Scholar
• Van Vliet RCJA. A statistical analysis of mandatory pooling across health insurance. j Risk & Insurance 67 (2), 197–217 (2000).
   Web of Science ®Google Scholar
• Epstein AM, Cumella EJ. Capitation payment: using predictors of medical utilization to adjust rates. Health Care Financing Rev. 10(1), 51–69 (1988).
   Google Scholar
• Giacomini M, Luft HS, Robinson JC. Risk adjusting community rated health plan premiums: a survey of risk assessment literature and policy applications. Ann. Rev Pub. Health 16,401–430 (1995).
   Google Scholar
• Newhouse JP, Manning WG, Keeler EB, Sloss EM. Adjusting capitation rates using objective health measures and prior utilization. Health Care Financing Rev 10(3), 41–54 (1989).
   PubMedGoogle Scholar
• Ash A, Porell F, Gruenberg L, Sawitz E, BeiserA. Adjusting medicare capitation payments using prior hospitalization data. Health Care Financing Rev. 10(4), 17–29 (1989).
   PubMedGoogle Scholar
• Anderson GP, Steinberg EP, Powe NR et al. Setting payment rates for capitated systems: a comparison of various alternatives. Inquiry27, 225–233 (1990).
   PubMed Web of Science ®Google Scholar
• Ellis RP, Ash A. Refinements to the diagnostic cost group (DCG) model. Inquiry32, 418–429 (1995).
   PubMed Web of Science ®Google Scholar
• Ellis RP, Pope GC, Iezonni LI et al Diagnosis-based risk adjustment for Medicare capitation payments. Health Cam Financing Rev 17(3), 101–128 (1996).
   PubMed Web of Science ®Google Scholar
• Lamers LM, Van Vliet RCJA. Multiyear diagnostic information from prior hospitalizations as a risk-adjuster for capitation payments. Med Cam 34(6), 549–561 (1996).
   Google Scholar
• Lamers LM Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation. Health Policy 45 (1), 15–32 (1998).
   PubMed Web of Science ®Google Scholar
• Hornbrook MC, Goodman MJ. Health plan case mix: definition, measurement, and use. In: Advances in Health Economics and Health Services Research, 12 Hornbrook MC (Ed.). JAI Press Inc., London, UK, 111–148 (1991).
   Google Scholar
• Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population-oriented measure of ambulatory care case-mix. Med Cam 29(5), 452–472 (1991).
   Google Scholar
• Weiner JP, Dobson A, Maxwell SL et al. Risk-adjusted medicare capitation rates using ambulatory and inpatient diagnoses. Health Cam Financing Rev 17(3), 77–99 (1996).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. j Clin. Epidemiol 45(2), 197–203 (1992).
   Google Scholar
• Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med. Care 33 (8), 783–795 (1995).
   PubMed Web of Science ®Google Scholar
• Lamers LM. Pharmacy costs groups: a risk- adjuster for capitation payments based on the use of prescribed drugs. Med Cam 37(8), 824–830 (1999).
   Google Scholar
• Lamers LM. Risk-adjusted capitation based on the diagnostic cost group model: an empirical evaluation with health survey information. Health Services Research 33 (6), 1727–1744 (1999).
   PubMed Web of Science ®Google Scholar
• Lamers LM. Health-based risk adjustment: is inpatient and outpatient diagnostic information sufficient? Inquiry 38 (4), 423–431 (2001).
   Google Scholar
• Gilmer T, Kronick R, Fishman P, Ganiats TG. The medicaid rx model, pharmacy-based risk adjustment for public programs. Med. Cam 39,1188–1202 (2001).
   Google Scholar
• Lamers LM, Van Vliet RCJA. health-based risk adjustment: improving the pharmacy-based cost group model to reduce gaming possibilities. Eur. j Health Econ. 4,107–114 (2003).
   PubMedGoogle Scholar
• •Provides more information on the development of the Pharmacy-based Cost Group model.
   Google Scholar
• Thomas JW, Lichtenstein R. Including health status in medicare's adjusted average per capita cost capitation formula. Med Cam 24(3), 259–275 (1986).
   Google Scholar
• PPRC (Physician Payment Review Commission). A comparison of alternative approaches to risk measurement. Selected external research series, number 1, Washington DC, USA (1994).
   Google Scholar
• Hornbrook MC, Goodman MJ. Chronic disease, functional health status, and demographics: a multidimensional approach to risk adjustment. Health Set-v. Res. 31(3), 283–307 (1996).
   Google Scholar
• Gruenberg L, Kaganova E, Hornbrook MC. Improving the AAPCC with health-status measures from the MCBS. Health Cam Financing Rev. 17(3), 59–75 (1996).
   PubMed Web of Science ®Google Scholar
• Hornbrook MC, Goodman MJ. Assessing relative health plan risk with the RAND-36 health survey. Inquiry 32(1), 56–74 (1995).
   Google Scholar
• Howland J, Stokes J, Crane SC, Belanger AJ. Adjusting capitation using chronic disease risk factors: a preliminary study. Health Cam Financing Rev. 9(2), 15–23 (1987).
   Google Scholar
• Schauffler HH, Howland J, Cobb J. Using chronic disease risk factors to adjust Medicare capitation payments. Health Cam Financing Rev 14(1), 79–90 (1992).
   PubMedGoogle Scholar
• Newhouse JP, Sloss EM, Manning WG, Keeler EB. Risk adjustment for a children's capitation rate. Health Cam Financing- Rev. 15(1), 39–54 (1993).
   Google Scholar
• Kronick R, Dreyfus T, Lee L, Zhou Z. Diagnostic risk adjustment for medicaid: the disability payment system. Health Care Financing Rev 17(2), 7–33 (1996).
   PubMedGoogle Scholar
• Beck K, Spycher S, Holly A, Gardiol L. Risk adjustment in Switzerland. Health Policy65 (1), 63–74 (2003).
   PubMed Web of Science ®Google Scholar
• Buchner F, Wasem J. Needs for further refinement: risk adjustment in the German health insurance system. Health Policy 65(1), 21–35 (2003).
   PubMed Web of Science ®Google Scholar
• Schokkaert E, Van de Voorde C. Belgium: risk adjustment and financial responsibility in a centralised system. Health Policy 65(1), 5–19 (2003).
   PubMed Web of Science ®Google Scholar
• Lamers LM, Van Vliet RCJA, Van de Ven WPMM. risk-adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands. Health Policy65 (1), 49–62 (2003).
   PubMed Web of Science ®Google Scholar
• Shen Y. Applying the 3M all patient refined diagnosis related groups grouper to measure inpatient severity in the VA. Med Cam 41 (Suppl. 6), 103–110 (2003).
   Google Scholar
• Kronick R, Gilmer T, Dreyfus T, Lee L. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financing Rev. 21(3), 29–64 (2000).
   Google Scholar
• Dunn DL. Applications of health risk adjustment: what can be learned from experience to date? Inquiry35(2), 132–147 (1998).
   Google Scholar
• Riley G, Rabey E, Kasper J. Biased selection and regression toward the mean in three medicare HMO demonstrations: a survival analysis of enrollees and disrollees. Med. Care 27(4), 337–351 (1989).
   Google Scholar
• Lichtenstein R, Thomas JW, Adams- Watson J et al Selection bias in TEFRA at-risk HMOs. Med Cam 29(4), 318–331 (1991).
   Google Scholar
• Hellinger FJ. Selection bias in HMOs and PPOs: a review of the evidence. Inquiry 32(2), 135–142 (1995).
   PubMed Web of Science ®Google Scholar
• Dowd B, Feldman R, Moscovice I et al An analysis of selectivity bias in the Medicare AAPCC. Health Cam Financing Rev 17(3), 35–57 (1996).
   PubMed Web of Science ®Google Scholar
• Greenwald LM, Esposito A, Ingber MJ, Levy JM. Risk adjustment for the medicare program: lessons learned from research and demonstrations. Inquir y35(2), 193–209 (1998).
   PubMed Web of Science ®Google Scholar
• Pope DC, Ellis RP, Ash A et al Principal Inpatient Diagnostic Cost Group Model for Medicare Risk Adjustment. Health Care Financing Rev 31 (3), 93–118 (2000).
   Google Scholar
• •Provides more information on the development of the principal inpatient-diagnostic costs group model.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification index. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway (2000).
   Google Scholar
• Van Vliet RCJA. Predictability of individual health care expenditures. J. Risk Insurance 59(3), 443–461 (1992).
   Web of Science ®Google Scholar
• Lamers LM, Van Vliet RCJA. Financiering van ziekenfondsen: met diagnose-informatie van zorggebruik in het verleden sluiten normuitkeringen beter aan bij de verwachte schades (Financing Dutch sickness funds: Diagnostic information from prior health care utilizations gives a better match between risk-adjusted capitation payments and expected costs). Het Verzekerings-Archief 80 (1), 16–20 (2003).
   Google Scholar